HAWK Biosystems is proud to announce a new distribution partnership with Sinapse Biotecnologia, aimed at expanding access to cutting-edge spatial biology and tumor microenvironment profiling across Brazil.
Together with Sinapse, we’re making next-generation spatial biology accessible to research institutions throughout Brazil—empowering scientists to better understand disease biology and accelerate breakthroughs in precision oncology.
A Strategic Alliance for Scientific Advancement
With over 25 years of experience, Sinapse is a trusted name in the distribution of advanced life science technologies across Brazil. Focused on academic and research institutions, the company blends national reach with deep scientific understanding to deliver innovative tools to the bench.
As the official distributor of HAWK Biosystems in Brazil, Sinapse will help bring HAWK’s spatial biology platform and tumor microenvironment technology to one of the most dynamic research communities in Latin America.
Delivering Disruptive Technology to the Brazilian Market
HAWK’s QF-Pro® technology provides researchers with a powerful new way to study functional biomarkers in situ—offering spatial, molecular, and interaction-level insights that go beyond traditional biomarker approaches.
Through this partnership, Brazilian institutions will gain access to tools that support deeper understanding of immune response, therapy resistance, and disease progression.
Shared Commitment to Innovation and Impact
“Partnering with HAWK Biosystems allows us to bring a disruptive spatial biology platform to researchers across Brazil. This collaboration strengthens our commitment to introducing innovative solutions that accelerate scientific discovery and expand access to precision oncology.”
— Carlos André Herklotz, Director at Sinapse Biotecnologia
Supporting the Future of Precision Oncology in Brazil
This partnership is more than a commercial collaboration—it’s a shared effort to enable scientific discovery and drive translational impact. Together, HAWK Biosystems and Sinapse are laying the foundation for a new era of cancer research in Brazil, grounded in functional spatial biology.
We look forward to supporting the research community and accelerating the adoption of next-generation tools that bring precision medicine closer to reality.
